Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study

References

• MEDICAL ECONOMICS COMPANY: Physicians' Desk Reference (Montvale, NJ: Medical Economics Co.), pp. 986–989,1999.
   Google Scholar
• GIANUTSOS, G., STEWARD, C. and DuNN, J. P.: Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine. European Journal of Pharmacology, 110: 357–361,1985.
   PubMed Web of Science ®Google Scholar
• ALLEN, R. M.: Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: Overview and pharmacology. Clinical Neuropharmacology, 6 (Supplement 1): S64—S73, 1983.
   Google Scholar
• MMWR: Antiviral agents for influenza A. Journal of the American Medical Association, 258: 599–600,1987.
   Google Scholar
• ATKINSON, W. L., ARDEN, N. H., PATNARCA, P. A. et al.: Amantadine prophylaxis during institutional outbreak of type A (H1N1) influenza. Archives of Internal Medicine, 146: 1791–1796,1986.
   Google Scholar
• GAULTIERI, C. T.: Neuropsychiatry and Behavioral Pharmacology (New York: Springer-Verlag), pp. 40–51,1991.
   Google Scholar
• GAULTIERI, C. T., CHANDLER, M. C., COONS, T. B. et al.: Amantadine: A new clinical profile for traumatic brain injury. Clinical Neuropharmacology, 12: 258–270,1989.
   PubMedGoogle Scholar
• ZASLER, N.: Advances in neuropharmacologicaI rehabilitation for brain dysfunction. Brain Injury, 6: 1–14,1992.
   PubMedGoogle Scholar
• BRADLEY, P. B.: Introduction to Neuropharmacology (Boston: Wright Publishing Co.), 1989.
   Google Scholar
• GRAHAM, D. I., ADAMS, J. H. and GENNRELLI, T. A.: Pathology of brain damage in head injury. In P. R. Copper (editor) Head Injury (Baltimore: Williams & Wilkins), pp. 72–88,1987.
   Google Scholar
• VECT, C. J., VAN WOEPKOM, T., TFFT KEN, A. W. et al.: Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. Archives in Neurology, 32: 792–797,1975.
   Google Scholar
• VAN WOERKOM, T., TEELKEN, A. W. and MINDERHOUD, J. M.: Difference in neurotransmitter metabolism in frontotemporal-lobe contusion and difuse cerebral contusion. Lancet, 1: 812–813, 1977.
   PubMedGoogle Scholar
• FEENEY, D. M., GONZALEZ, A. and LA W. A.: Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex surgery. Science, 217: 855–857,1982.
   PubMed Web of Science ®Google Scholar
• KASAMATUSU, T., PETTIGREW, J. K. and A RY, M.: Cortical recovery from effects of monocular deprivation: acceleration with norepinephrine and suppression with 6-hydroxydoparnine. Journal of Neurophysiology, 45: 139–162,1981.
   Google Scholar
• GAULTIERI, C. T. and EVANS, R. W.: Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Injury, 2: 273–290,1988.
   PubMedGoogle Scholar
• EVANS, R. W., GAULTIERI, C. T. and PATTERSON, D.: Treatment of chronic closed head injury with psychostimulant drugs: A controlled case study and an appropriate evaluation procedure. Journal of Nervous and Mental Disease, 175: 106–110,1987.
   PubMed Web of Science ®Google Scholar
• GAULTIERI, C. T.: Pharrnacotherapy and the neurobehavioral sequelae of traumatic brain injury. Brain Injury, 2: 101–129,1988.
   PubMedGoogle Scholar
• CHANDLER, M. C., BARNHILL, J. L. and GUALTIERI, C. T.: Case Studies: Amantadine for the agitated head-injury patient. Brain Injury, 2: 309–311,1988.
   PubMedGoogle Scholar
• KRAUS, M. F. and MAKI, P.: The combined use of amantadine and 1-dopa/carbidopa in the treatment of chronic brain injury. Brain Injury, 11: 455–460,1997.
   Google Scholar
• ZAFONTE, R. D., WATANABE, T. and MAN N. R.: Amantadine: a potential treatment for the minimally conscious state. Brain Injury, 12: 617–621,1998.
   PubMed Web of Science ®Google Scholar
• NICKELS, J. L., SCHNEIDER, W. N., DOMBOVY, M. L. et al.: Clinical use of amantadine in brain injury rehabilitation. Brain Injury, 8: 709–718,1994.
   PubMed Web of Science ®Google Scholar
• LEVIN, H. S., O'DoNNEL, V. M. and GROSSMAN, R. G.: The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. Journal of Nervous and Mental Diseases, 167: 675–684,1979.
   Google Scholar
• WILSON, B., COCKBURN, J., BAHHELEY, A. et al.: The development and validation of a test battery for detecting and monitoring everyday memory problems. Journal of Clinical and Experimental Neuropsychology, 11: 855–870,1989.
   PubMed Web of Science ®Google Scholar
• REITAN, R. and WOLFSON, D.: The Halstead-Reitan Neuropsychological Test Battery (Tuscon: Neuropsychology Press), 1985.
   Google Scholar
• WECHSLER, D.: Wechsler Memory Scale—Revised (New York: Psychological Corporation), 1987.
   Google Scholar
• LEZAK, M.: Neuropsychological Assessment, 2nd edn (New York: Oxford University Press), 1983.
   Google Scholar
• DILLER, L., BEN-YISHAY, Y., GERSTMAN, L. J. et al.: Studies in cognition and rehabilitation in hemiplegia (Rehabilitation Monograph No. 50) (New York: New York University Medical Center Institute of Rehabilitation Medicine), 1974.
   Google Scholar
• KAPLAN, E., CooDoLASS, G. and WEINTRAUB, S.: The Boston Naming Test, 2nd edn. (Philadelphia: Lea & Febiger), 1983.
   Google Scholar
• BENTON, A . L: Revised Visual Retention Test, 4th edn (New York: the Psychological Corporation), 1974.
   Google Scholar
• PURDUE RESEARCH FOUNDATION: Examiner's manual for the Purdue Pegboard (Chicago: Science Research Associates), 1948.
   Google Scholar
• LEVIN, H., HIGH, W GOETHE, K. et al.: The neurobehavioral rating scale: assessment of the behavioral sequelae of head injury by the clinician. Journal of Neurology, Neurosurgery, and Psychiatry, 50: 183–193,1987.
   Google Scholar
• FEENEY, D. M. and SUTTON, R. L.: Pharrnacotherapy for recovery of function after brain injury. CDC Critical Review Neurobiology, 3: 135–197,1987.
   PubMed Web of Science ®Google Scholar
• CORRIGAN, J. D. and BOGNER, J. A.: Assessment of agitation following brain injury. NeuroRehabilitation, 5: 205–210,1995.
   PubMed Web of Science ®Google Scholar